Skip to content
July 29, 2026
  • TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration
  • HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu
  • Haryana Issues Standard Operating Guidelines for Withdrawal of Life Support
  • Johnson & Johnson Agrees to $5.5 Billion Settlement in Talc Cancer Lawsuits
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Bone Marrow Cancer

Bone Marrow Cancer

Bone Marrow Cancer
  • Global Healthcare
  • Healthcare Education

Bone Marrow Cancer Breakthrough: Revolutionary Drug Offers New Hope for Treating Rare Blood Disorders

tishha_newsSeptember 27, 2024September 27, 2024010 mins

Bone Marrow Cancer Drug Shows Promising Success in Treating Blood Disorder, Study Reveals Bone Marrow Cancer treatment has taken an…

Read More

Most Viewed

News
TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration
TISHHA Consultants LLP proudly marks its 2nd Foundation Day, celebrating…
News
HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu
HDFC Bank, under its flagship CSR programme Parivartan, has joined…

Random

1

TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration

  • News
2

HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu

  • News
3

Haryana Issues Standard Operating Guidelines for Withdrawal of Life Support

  • News
4

Johnson & Johnson Agrees to $5.5 Billion Settlement in Talc Cancer Lawsuits

  • News
5

IMA CGP South Zone Conference 2026 Successfully Held in Kozhikode

  • News
6

CAG Flags Non-Functional Oxygen Plants and Unspent COVID Funds in West Bengal

  • News
7

SGPGI Launches Advanced OPD Lab for Head and Neck Cancer Care

  • News
8

First Human Receives Experimental Vaccine Against Rare Bundibugyo Ebola Virus

  • Global Healthcare
tishha_logo
TISHHA News Developed By BlazeThemes.